These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 15420232)

  • 41. Antityphoid vaccination in children.
    Russell FF
    JAMA; 2013 May; 309(17):1758. PubMed ID: 23632695
    [No Abstract]   [Full Text] [Related]  

  • 42. [EVALUATION OF VACCINES AND OF THE EFFECTIVENESS OF VACCINATIONS AGAINST TYPHOID FEVER. II. THE S. TYPHI ANTIBODY PICTURE IN THE POPULATION DESIGNATED FOR THE CONTROL OF ANTI-TYPHOID VACCINATION].
    KOPACKA B; SLUBICKA A
    Przegl Epidemiol; 1963; 17():13-21. PubMed ID: 14053741
    [No Abstract]   [Full Text] [Related]  

  • 43. [Tuberculosis provoked by antidiphtheria-tetanus-typhoid-paratyphoid A and B vaccine].
    RAYMOND A
    Hopital; 1953 Jan; 41(618):10. PubMed ID: 13068913
    [No Abstract]   [Full Text] [Related]  

  • 44. The combined injection of vitamins and vaccines, with a note on typhoid agglutination titres.
    McPHEDRAN FM
    Trans Stud Coll Physicians Phila; 1946 Apr; 14():18. PubMed ID: 20993970
    [No Abstract]   [Full Text] [Related]  

  • 45. [Characterization of typhoid O and H agglutinins and paratyphoid A and B agglutinins in full-term newborn infants after stimulation with typhoid-paratyphoid vaccine].
    Turbessi G; Ungari S; Aiuti F; Serra GB; Ricci G
    Riv Ist Sieroter Ital; 1966; 41(4):255-63. PubMed ID: 4966014
    [No Abstract]   [Full Text] [Related]  

  • 46. [EVALUATION OF VACCINES AND THE EFFECTIVENESS OF VACCINATIONS AGAINST TYPHOID FEVER. III. SELECTION AND PRELIMINARY CHARACTERISTICS OF VACCINES DESIGNATED FOR CONTROL VACCINATIONS].
    KRUCZALOWA M; SCHILLEROWA B
    Przegl Epidemiol; 1963; 17():23-32. PubMed ID: 14053743
    [No Abstract]   [Full Text] [Related]  

  • 47. [Treatment of patients with typhoid and paratyphoid fever by use of typhoid-paratyphoid B vaccines with the aim of prevention of carrier state formation].
    Bilibin AF; Kornilova II; Antonova IV; Kilesso VA; Riadneva OE; Taratorina OM; Izmaĭlova NB; Khazanova LE
    Klin Med (Mosk); 1965 Aug; 43(8):112-7. PubMed ID: 4957973
    [No Abstract]   [Full Text] [Related]  

  • 48. [EVALUATION OF VACCINES AND OF THE EFFECTIVENESS OF VACCINATIONS AGAINST TYPHOID FEVER. IX. USE OF THE PHAGOCYTESIS TEST IN THE EVALUATION OF THE EFFECTIVENESS OF VACCINATIONS AGAINST TYPHOID FEVER. (PRELIMINARY COMMUNICATION)].
    LADOSZ J
    Przegl Epidemiol; 1963; 17():63-70. PubMed ID: 14053746
    [No Abstract]   [Full Text] [Related]  

  • 49. Large scale manufacture of T.A.B. vaccine in India.
    ANDLEIGH HS
    Antiseptic; 1951 Jan; 48(1):22-6. PubMed ID: 14820039
    [No Abstract]   [Full Text] [Related]  

  • 50. TYPHOID AND PARATYPHOID FEVERS IN THE TROPICS.
    ASHCROFT MT
    J Trop Med Hyg; 1964 Aug; 67():185-9. PubMed ID: 14179764
    [No Abstract]   [Full Text] [Related]  

  • 51. Studies on the effectiveness of and reactions to adsorbed bacillary typhoid vaccine.
    BARSY G; TOLNAI G
    Acta Microbiol Acad Sci Hung; 1956; 3(4):373-82. PubMed ID: 13354307
    [No Abstract]   [Full Text] [Related]  

  • 52. Duration of postvaccination antityphoid immunity according to the results of strictly controlled field trials.
    Hejfets LB
    J Hyg Epidemiol Microbiol Immunol; 1969; 13(2):154-65. PubMed ID: 5817422
    [No Abstract]   [Full Text] [Related]  

  • 53. [EVALUATION OF VACCINES AND THE EFFECTIVENESS OF ANTI-TYPHOID VACCINATION. XIX. SEROLOGICAL REACTIONS IN SUBJECTS VACCINATED WITH VARIOUS ANTI-TYPHOID VACCINES].
    LUTYNSKI R
    Przegl Epidemiol; 1964; 18():347-53. PubMed ID: 14295116
    [No Abstract]   [Full Text] [Related]  

  • 54. [Synthetic chloramphenicol alone and combined with vaccine in treatment of typhoid].
    MUSOTTO F
    G Med Mil; 1950; 97(4):364-76. PubMed ID: 14773850
    [No Abstract]   [Full Text] [Related]  

  • 55. [Anti-typhoid vaccines].
    Morand P; Stahl JP
    Rev Prat; 1992 Nov; 42(18):2292-4. PubMed ID: 1296295
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Postvaccination signs and symptoms following antityphoid vaccination].
    García-Gonzádez J; Cárdenas-Romero C; García de Alba JE
    Salud Publica Mex; 1978; 20(1):79-85. PubMed ID: 752935
    [No Abstract]   [Full Text] [Related]  

  • 57. [Variations of serum proteins during typhoid vaccine therapy of eye diseases].
    MANNA F
    Klin Oczna; 1955; 25(2):103-12. PubMed ID: 13252830
    [No Abstract]   [Full Text] [Related]  

  • 58. Vaccines against typhoid fever.
    Guzman CA; Borsutzky S; Griot-Wenk M; Metcalfe IC; Pearman J; Collioud A; Favre D; Dietrich G
    Vaccine; 2006 May; 24(18):3804-11. PubMed ID: 16278037
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Controlled field trials of killed oral typhoid and paratyphoid B vaccines and cell-free, chemical aerosol typhoid vaccine.
    Hejfec LB; Levina LA; Salmin LB; Antonova AA; Segal LS; Kuzminova ML; Slavina KM; Vasileva AV
    Dev Biol Stand; 1976; 33():93-7. PubMed ID: 821803
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Associated vaccine-antibiotic therapy of typhoid].
    D'ANTONIO F
    Rass Int Clin Ter; 1950 Jul; 30(13):387-90. PubMed ID: 14781392
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.